Louis Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Louis Lin has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Harvey Wong
Faculty of Pharmaceutical Sciences The University of British Columbia Vancouver British Columbia Canada
1 shared publication
Latest Publications
- Open Access
- 26 September 2017
- Published by MDPI AG in Pharmaceutics
- Vol. 9 (4) , 41
Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
Most marketed drugs are administered orally, despite the complex process of oral absorption that is difficult to predict. Oral bioavailability is dependent on the interplay between many processes that are dependent on both compound and physiological properties. Because of this complexity, computational oral physiologically-based pharmacokinetic (PBPK) models have emerged as a tool to integrate these factors in an attempt to mechanistically capture the process of oral absorption. These models use inputs from in vitro assays to predict the pharmacokinetic behavior of drugs in the human body. The most common oral PBPK models are compartmental approaches, in which the gastrointestinal tract is characterized as a series of compartments through which the drug transits. The focus of this review is on the development of oral absorption PBPK models, followed by a brief discussion of the major applications of oral PBPK models in the pharmaceutical industry.
- 26 September 2017
- Published by MDPI AG in Pharmaceutics
- Vol. 9 (4) , 41
Open AccessPredicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
Most marketed drugs are administered orally, despite the complex process of oral absorption that is difficult to predict. Oral bioavailability is dependent on the interplay between many processes that are dependent on both compound and physiological properties. Because of this complexity, computational oral physiologically-based pharmacokinetic (PBPK) models have emerged as a tool to integrate these factors in an attempt to mechanistically capture the process of oral absorption. These models use inputs from in vitro assays to predict the pharmacokinetic behavior of drugs in the human body. The most common oral PBPK models are compartmental approaches, in which the gastrointestinal tract is characterized as a series of compartments through which the drug transits. The focus of this review is on the development of oral absorption PBPK models, followed by a brief discussion of the major applications of oral PBPK models in the pharmaceutical industry.